Table 1. Patient demographics.
| EUS-GBD patients with cirrhosis (n = 15) | ||
| Age, mean ± SD | 61 | 17.1 |
| Number of females (%) | 9 | 60 |
| Etiology of cirrhosis | ||
| Chronic Hepatitis C virus, n (%) | 2 | 13 |
| Alcohol, n (%) | 4 | 27 |
| Non-alcoholic fatty liver disease, n (%) | 8 | 53 |
| Autoimmune, n (%) | 1 | 7 |
| Child-Pugh class | ||
| A | 3 | 20 |
| B | 10 | 67 |
| C | 2 | 13 |
| Ascites grade at time of procedure | ||
| 0 | 5 | 33 |
| 1 | 7 | 47 |
| 2 | 3 | 20 |
| 3 | 0 | 0 |
| INR at time of procedure | ||
| < 1.5 | 8 | 53 |
| 1.5 – 2.5 | 7 | 47 |
| MELD-Na, mean ± SD | 15 | 7 |
| Indication for EUS-GBD | ||
| Acute cholecystitis, n (%) | 11 | 73 |
| Chronic cholecystitis, n (%) | 2 | 13 |
| Recurrent gallstone pancreatitis, n (%) | 2 | 13 |
| Surgical consultation for cholecystectomy, n (%) | 9 | 60 |
| Indwelling percutaneous cholecystostomy tube, n (%) | 3 | 20 |
EUS-GBD, endoscopic ultrasound-guided gallbladder drainage; SD, standard deviation; INR, international normalized ratio; MELD, model for end-stage liver disease.